Tennor Therap-b
Status: Publicly traded
Direct answer
Tennor Therap-b is publicly traded on HKSE under the ticker 6872.HK.
TenNor Therapeutics (Suzhou) Limited engages in discovery, development and commercialization of differentiated therapies for diseases associated with bacterial infections and bacterial metabolism. The company's offerings include drug production and medical research and experimental development, with a pipeline of products such as Rifasutenizole (TNP-2198) for treatment of Helicobacter pylori infection; Rifaquizinone...
Can you invest in Tennor Therap-b?
Yes. Tennor Therap-b trades publicly on HKSE as 6872.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Tennor Therap-b
Detailed equity research is provided by MarketSnap.